Author(s):
Job Herman Berkhout, Aswatha Ram H. N., Mahalaxmi Rathnanand
Email(s):
aswatharam@gmail.com
DOI:
10.52711/0974-360X.2021.00478
Address:
Job Herman Berkhout1, Aswatha Ram H. N.2*, Mahalaxmi Rathnanand3
1Faculty of Science, Radboud University, Nijmegen, the Netherlands.
2Department of Pharmacognosy, Manipal College of Pharmaceutical Sciences,
Manipal Academy of Higher Education, Manipal - 576104, India.
3Department of Pharmaceutics, Manipal College of Pharmaceutical Sciences,
Manipal Academy of Higher Education, Manipal - 576104, India.
*Corresponding Author
Published In:
Volume - 14,
Issue - 5,
Year - 2021
ABSTRACT:
Proper knowledge of the pKa value of a compound is of uttermost importance for understanding the behavior of a drug inside the body. The pKa value of Nonselective alpha-1 and beta-blocker Carvedilol shows controversies in literature, whereas values between 7.7 and 8.7 have been previously reported. In this research paper, the pKa value of Carvedilol was re-evaluated using UV-vis spectroscopy. The analytical wavelength used was 241nm. The obtained sigmoid pattern was non-linear fitted using the Boltzmann sigmoidal algorithm. The determined pKa was 7.77 ± 0.09. This value is in accordance with some of the literature publications. Since extensive statistics and multiple replicate experiments were performed, it is assumed that 7.8 is the true pKa value of Carvedilol.
Cite this article:
Job Herman Berkhout, Aswatha Ram H. N., Mahalaxmi Rathnanand. pKa Determination of Carvedilol by Spectrophotometry. Research Journal of Pharmacy and Technology. 2021; 14(5):2714-6. doi: 10.52711/0974-360X.2021.00478
Cite(Electronic):
Job Herman Berkhout, Aswatha Ram H. N., Mahalaxmi Rathnanand. pKa Determination of Carvedilol by Spectrophotometry. Research Journal of Pharmacy and Technology. 2021; 14(5):2714-6. doi: 10.52711/0974-360X.2021.00478 Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2021-14-5-62
REFERENCES:
1. Dardonville C. Automated techniques in pKa determination: Low, medium and high-throughput screening methods.Drug Discovery Today Technologies. 2018; 27: 49-58.
2. Manallack DT. The pKa Distribution of Drugs: Application to Drug Discovery. Perspectives in Medicinal Chemistry. 2007; 1: 25-38.
3. National Center For Biotechnology and Informatics (NCBI). PubChem Compound Database; CID=2585.[Online]. Available: https://pubchem.ncbi.nlm.nih.gov/compound/2585. [Accessed 04 02 2019].
4. Hamed R. et al. pH-Dependent Solubility and Dissolution Behavior of Carvedilol—Case Example of a Weakly Basic BCS Class II Drug.AAPS PharmSciTech. 2015; 17: 418-26.
5. Pandey M. et al. Determination of pKa of felodipine using UV–Visible spectroscopy.Spectrochimica Acta Part A Molecular and Biomolecualr Spectroscopy. 2013; 115: 887-90.
6. SPARC pKa server version 4.5, "pubchem," Archemical SPARC, October 2011. [Online]. Available: https:// pubchem.ncbi.nlm.nih.gov/compound/carvedilol. [Accessed February 2019].
7. Marques M. et al. Study of carvedilol by combined Raman spectroscopy and ab initio MO calculations. Journal of Raman Spectroscopy. 2002; 33: 778-83.
8. Hoffman B. Adrenergic receptor antagonist in Hardman JG, Limbird LE, Gilman AG, editors. Goodman and Gilman’s The Pharmacological Basis of Therapeutics, New York, McGraw Hill, 2001;pp. 249-69.
9. Aktas E. et al. Systematic development of pH-independent controlled release tablets of carvedilol using central composite design and artificial neural networks. Drug Development and Industrial Pharmacy. 2013; 39:1207-16.
10. Babic S. et al.Determination of pKa values of active pharmaceutical ingredients. Trends in Analytical Chemistry. 2007; 26: 1043-61.
11. Reijenga J. et al. Development of Methods for the Determination of pKa Values. Analtical Chemistry Insights. 2013; 8: 53-71.
12. Sevcik C. Caveat on the Boltzmann distrubution function use in biology. Progress in Biophysics and Molecualr Biology. 2017; 127: 33-42.